Analyze Diet
Analytica chimica acta2006; 586(1-2); 208-216; doi: 10.1016/j.aca.2006.09.053

Metabolic studies of turinabol in horses.

Abstract: Turinabol (4-chloro-17alpha-methyl-17beta-hydroxy-1,4-androstadien-3-one) is a synthetic oral anabolic androgenic steroid. As in the case of other anabolic steroids, it is a prohibited substance in equine sports. The metabolism of turinabol in human has been reported previously; however, little is known about its metabolic fate in horses. This paper describes the studies of both the in vitro and in vivo metabolism of turinabol in racehorses with an objective to identify the most appropriate target metabolites for detecting turinabol administration. For the in vitro studies, turinabol was incubated with fresh horse liver microsomes. Metabolites in the incubation mixture were isolated by liquid-liquid extraction and analysed by gas chromatography-mass spectrometry (GC-MS) after trimethylsilylation. The results showed that the major biotransformation of turinabol was hydroxylation at the C6, C16 and C20 sites to give metabolites 6beta-hydroxyturinabol (M1), 20-hydroxyturinabol (M2), two stereoisomers of 6beta,16-dihydroxyturinabol (M3a, M3b) and 6beta,20-dihydroxyturinabol (M4). The metabolite 6beta-hydroxyturinabol was confirmed using an authentic reference standard. The structures of all other turinabol metabolites were tentatively identified by mass spectral interpretation. For the in vivo studies, two horses were administered orally with turinabol. Pre- and post-administration urine samples were collected for analysis. Free and conjugated metabolites were isolated using solid-phase extraction and analysed by GC-MS as described for the in vitro studies. The results revealed that turinabol was extensively metabolised and the parent drug was not detected in urine. Two metabolites detected in the in vitro studies, namely 20-hydroxyturinabol and 6beta,20-dihydroxyturinabol, these were also detected in post-administration urine samples. In addition, 17-epi-turinabol (M5) and six other metabolites (M6a-M6c and M7a-M7c), derived from D-ring hydroxylation and A-ring reduction, were also detected. Except for 17-epi-turinabol, none of these metabolites has ever been reported in any species. All in vivo metabolites were detected within 48 h after administration.
Publication Date: 2006-10-04 PubMed ID: 17386713DOI: 10.1016/j.aca.2006.09.053Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research conducted analyses the metabolism of a synthetic, orally administered anabolic androgenic steroid, Turinabol, in horses. The objective of the study was to identify the most significant metabolites for detecting the usage of Turinabol in horse racing sport.

Methodology

  • The research was conducted through both in vitro and in vivo studies. In the in vitro experiment, Turinabol was subjected to horse liver microsomes. After Turinabol’s incubation, the metabolites were isolated by a process known as liquid-liquid extraction and then analysed using gas chromatography-mass spectrometry (GC-MS).
  • In the in vivo studies, the researchers administered turinabol orally to two horses. Urine samples were collected both before and after administration for analysis. Metabolites in the urine were isolated through solid-phase extraction and then examined using the same technique as in the in vitro studies (GC-MS).

Findings

  • The in vitro studies showed that the major biotransformation of turinabol was hydroxylation at the C6, C16 and C20 sites which produced metabolites 6beta-hydroxyturinabol, 20-hydroxyturinabol, two stereoisomers of 6beta,16-dihydroxyturinabol and 6beta,20-dihydroxyturinabol. The metabolite 6beta-hydroxyturinabol was validated using an authentic reference standard while the structures of the other metabolites were identified using mass spectral interpretation.
  • The in vivo studies demonstrated that turinabol was extensively metabolised and the parent drug could not be detected in urine. The two metabolites detected in the in vitro studies, 20-hydroxyturinabol and 6beta,20-dihydroxyturinabol were also detected in post-administration urine samples. Additionally, 17-epi-turinabol and six other metabolites derived from D-ring hydroxylation and A-ring reduction were detected. These metabolites have not been reported in any species except for 17-epi-turinabol.
  • All in vivo metabolites were detected within 48 hours following administration.

Implications

  • This research has practical implications for racehorse doping controls. By understanding the metabolism of turinabol in horses, officials can detect its use more effectively.
  • The identified metabolites can serve as targets for testing. It further provides a broader understanding of how synthetic steroids behave in a horse’s body, contributing valuable knowledge to the field of equine sports science.

Cite This Article

APA
Ho EN, Kwok WH, Leung DK, Wan TS, Wong AS. (2006). Metabolic studies of turinabol in horses. Anal Chim Acta, 586(1-2), 208-216. https://doi.org/10.1016/j.aca.2006.09.053

Publication

ISSN: 1873-4324
NlmUniqueID: 0370534
Country: Netherlands
Language: English
Volume: 586
Issue: 1-2
Pages: 208-216

Researcher Affiliations

Ho, E N M
  • Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, NT, Hong Kong, China. emmie.nm.ho@hkjc.org.hk
Kwok, W H
    Leung, D K K
      Wan, T S M
        Wong, A S Y

          MeSH Terms

          • Administration, Oral
          • Animals
          • Biotransformation
          • Clinical Trials as Topic
          • Gas Chromatography-Mass Spectrometry
          • Horses
          • Microsomes / chemistry
          • Microsomes / metabolism
          • Reference Standards
          • Solid Phase Extraction / methods
          • Steroids / analysis
          • Steroids / chemistry
          • Substance Abuse Detection / methods
          • Testosterone / analogs & derivatives
          • Testosterone / analysis
          • Testosterone / metabolism
          • Testosterone / urine
          • Time Factors
          • Trimethylsilyl Compounds / chemistry
          • Urinalysis / methods

          Citations

          This article has been cited 0 times.